An in Vitro Micromethod for Drug Sensitivity Testing of Leishmania

Joan E. JacksonDepartment of Parasitology, Division of Experimental Therapeutics, and Department of Biostatistics and Applied Mathematics, Division of Biometrics, Walter Reed Army Institute of Research, Washington, DC

Search for other papers by Joan E. Jackson in
Current site
Google Scholar
PubMed
Close
,
John D. TallyDepartment of Parasitology, Division of Experimental Therapeutics, and Department of Biostatistics and Applied Mathematics, Division of Biometrics, Walter Reed Army Institute of Research, Washington, DC

Search for other papers by John D. Tally in
Current site
Google Scholar
PubMed
Close
, and
Douglas B. TangDepartment of Parasitology, Division of Experimental Therapeutics, and Department of Biostatistics and Applied Mathematics, Division of Biometrics, Walter Reed Army Institute of Research, Washington, DC

Search for other papers by Douglas B. Tang in
Current site
Google Scholar
PubMed
Close
View More View Less
Restricted access

We describe an in vitro microtest which is quantitative, rapid, and readily applicable to parasites isolated from all major forms of human leishmaniasis. It is based on drug-mediated inhibition of promastigote catabolism of a battery of simple 14C-substrates to 14CO2. Each test requires < 1µCi. The test is conducted in a serum-free, chemically defined medium containing 120 µg protein/ml, minimizing the possible interference of drug: serum protein interaction. Prior adaptation is not necessary to cultivate “difficult-to-grow” species. Leishmania sensitivity to pentavalent antimonials is detectable at µg levels below concentrations achievable in patients' sera.

Save